x min read

Volatile Stocks in List: E. I. du Pont de Nemours and Company (NYSE:DD), TCF Financial Corporation (NYSE:TCB), FLIR Systems, Inc. (NASDAQ:FLIR), Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE)

Volatile Stocks in List: E. I. du Pont de Nemours and Company (NYSE:DD), TCF Financial Corporation (NYSE:TCB), FLIR Systems, Inc. (NASDAQ:FLIR), Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE)
Written by
Ryan Mitchell
Published on
October 27, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

Chemical firm, E. I. du Pont de Nemours and Company (NYSE:DD) reported that it has appoints James Collins, Jr. and Matthew Trerotola, both currently senior VP, as executive VP and members of the company's Office of the Chief Executive (OCE), effective December 1. E. I. du Pont de Nemours and Company (NYSE:DD) has the market capitalization of 63.152 Billion. Shares of firm climbed 0.60% to close at $69.00 with the total traded volume of 4.54 Million. The firm has current ratio of 1.90 for the most recent quarter.TCF Financial Corporation (NYSE:TCB) reported on Friday that its third-quarter net income attributable to the firm moved up to $52.32M or $0.29 a share from $42.8M or $0.23 per share last year. The analysts' anticipates typically exclude special items. TCF Financial Corporation (NYSE:TCB) begun last trade with a price of $15.26 and throughout the trading session climbed at a high of $15.30. The day-trade ended with -3.48% to $14.68. The stock is going forward to its 52 week low with 5.23% and lagging behind from its 52 week high price with -15.03%. TCB last month stock price volatility remained 2.16%.FLIR Systems, Inc. (NASDAQ:FLIR) released on Friday that third-quarter net earnings of $52.9M or $0.37 a share, increased from $46.5M or $0.32 per share in the earlier year. The current quarter results were impacted by net after tax restructuring charges of $0.02 per share. FLIR Systems, Inc. (NASDAQ:FLIR) stock price closed at $32.04 with the total traded volume of 1.86 Million shares. Its price to sales ratio ended at 3.07. Its market capitalization is 4.541 Billion. The stock owned by the Financial Institutions was 99.40% while by insiders was 1.10%.Shares of Vitae Pharmaceuticals Inc (NASDAQ:VTAE) rose over 5.3% in last session following the clinical-stage biotechnology firm reported positive top-line results from clinical trials in treatment and prevention of Alzheimer's disease.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.